感染和中性粒细胞减少症都没有增加。
There was no increase in infections or neutropenia with rituximab.
血小板减少症是动物最常见的出血性疾病之一。
Thrombocytopenia is one of the most common bleeding disorders of animals.
目的报告一组与异常免疫相关的全血细胞减少症。
Objective a report of a group of patients with pancytopenia which might be related to abnormal immunity.
近10年我院收治药物所致急性粒细胞减少症33例。
We treated 33 cases of acute granulocytopenia caused by drugs in recent 10 years.
血小板减少症表现为血小板计数过低，是犬类常见疾病。
Thrombocytopenia is a common condition in dogs characterized by low platelet counts.
目的：探讨血小板相关抗体在血小板减少症中的临床应用。
Objective: to study the clinical appliance of platelet associated antibody in thrombocytopenic diseases.
目的观察地榆升白片对妇科肿瘤化疗中白细胞减少症的疗效。
Objective To observe the curative effect of burnet root leukopoietic tablets on leukopenia caused by chemotherapy of gynecological tumor.
观察健脾补肾中药对恶性肿瘤化疗病人的白细胞减少症的作用。
Objective To observe the effect of spleen-strengthening and kidney-reinforcing method on leukopenia in patients with malignant tumor after chemotherapy.
目的观察地榆升白片预防NP方案化疗患者白细胞减少症的疗效。
Objective To observe clinical effect of Diyushengbai tablet on preventing leukopenia caused by NP chemotherapy.
血小板疾病是定量的(血小板减少症或血小板增多症)或是定性的(血小板病)。
Platelet disorders are either quantitative (thrombocytopenia or thrombocytosis) or qualitative (thrombocytopathy).
目的探讨推拿疗法对骨骼肌减少症患者伸膝速度和肌电信号的干预作用。
ObjectiveTo study the effects of Chinese massage on knee extension velocity and electromyogram in sarcopenia.
目的：以放射线处理建立小鼠淋巴细胞减少症模型并探讨其免疫学意义。
Objective: To establish a mouse lymphopenia model via irradiation and to study its immune characteristics.
目的观察血小板减少症患者脾动脉栓塞术前后的脾动脉血流动力学的变化。
Objective It is to study the hemodynamic changes of the splenic artery in thrombocytopenia patients before and after therapeutic splenic artery embolization.
粒细胞集落刺激因子(G - CSF)主要用于各种原因引起的粒细胞减少症。
Granulocyte colony-stimulating factor (G-CSF) is mainly used to treat neutropenia induced by all causes.
结论：以放射线处理成功建立淋巴细胞减少症模型，并具有增强免疫保护的效应。
Conclusion: lymphopenia mouse model is successfully established and an enhanced immune protection can be induced under the lymphopenia status.
过量使用治疗血小板减少症的药物，如血小板生长因子，也会导致血小板增多症。
Over-medication with drugs that treat thrombocytopenia, such as eltrombopag or romiplostim, may also result in thrombocytosis.
特发性全血细胞减少症组临床随访时间的中位数和均值分别是444和739天。
Median and mean clinical follow-up for the idiopathic pancytopenia group was available for 444 and 739 days, respectively.
生长激素减少是造成骨骼肌减少症的诸多因素之一，它在发病中的作用需要被证明。
The decline of growth hormone in the development of sarcopenia is one of many factors, and its etiologic role needs to be demonstrated.
目的了解丙基硫氧嘧啶(PTU)致粒细胞减少症的发病情况、临床表现及治疗对策。
To clarify the onset, development, clinical manifestations and management of propylthiouracil (PTU) -induced granulocytopenia.
这是一种新的血小板生成剂治疗儿童免疫性血小板减少症（ITP）的首例研究成果。
This is the first publication of the results of one of the new thrombopoietic agents in the treatment of children with immune thrombocytopenia (ITP).
应该知道，不可能看到某个人患有血小板减少症，而其他有形成分仍为正常水平的情况。
It should be noted that it would be most unexpected to observe a person with thrombocytopenia that was not at least accompanied by a low normal level of the other formed blood elements.
结论原发性骨量减少症的防治重点在中老年男性，对女性原发性骨量减少症也不可忽视。
Conclusion Although prevention and treatment of primary osteopenia were important strategy in males however it should not be ignored in females as well.
较低的活动能力与剂量减少的上升、3 -4级嗜中性白血球减少症发生率的上升有关。
Lower performance status was associated with an increased need for dose reductions and an increased incidence of grade 3-4 neutropenia.
目的：分析消化道溃疡大出血手术治疗后引发血小板减少症(TCP)的原因及临床意义。
Objective: to study the causes and clinical relevance of thrombocytopenia (TCP) after operation for lethal peptic ulcer hemorrhage.
结果：218例乳腺癌患者中，罹患严重中性粒细胞减少症的共170例，占78.0％。
RESULTS: Among 218 breast cancer patients, 170 patients suffered from severe neutropenia, accounting for 78.0%.
目的分析特发性CD 4 + T淋巴细胞减少症的临床特点，并探讨其发病机制和治疗。
Objectives to explore the clinical features and treatment of idiopathic CD4 + T-lymphocytopenia.
目的分析特发性CD 4 + T淋巴细胞减少症的临床特点，并探讨其发病机制和治疗。
Objectives to explore the clinical features and treatment of idiopathic CD4 + T-lymphocytopenia.
应用推荐